✦ LIBER ✦

Half-genome human immunodeficiency virus type 1 constructs for rapid production of reporter viruses

✍ Scribed by Ayub Ali; Beth D. Jamieson; Otto O. Yang

Book ID: 114140074
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 280 KB
Volume: 110
Category: Article
ISSN: 0166-0934
DOI: 10.1016/s0166-0934(03)00110-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A heteroduplex assay for the rapid detec

A heteroduplex assay for the rapid detection of dual Human Immunodeficiency Virus Type 1 infections

✍ Rebecca L.R. Powell; Mateusz M. Urbanski; Phillipe N. Nyambi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 802 KB

A rapid label-free method for quantitati

A rapid label-free method for quantitation of human immunodeficiency virus type-1 particles by nanospectroscopy

✍ Olivia Block; Anirban Mitra; Lukas Novotny; Carrie Dykes 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Green fluorescence protein as a transcri

Green fluorescence protein as a transcriptional reporter for the long terminal repeats of the human immunodeficiency virus type 1

✍ Anindita Kar-Roy; Wei Dong; Nelson Michael; Yen Li 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Performance characteristics of a rapid w

Performance characteristics of a rapid western blot assay system for antibody to human immunodeficiency virus type 1

✍ Olajide Agbede; Syed Wahab; Donna L. Schutt; Helen L. Lucia 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 697 KB

A sensitive PCR assay system for the qua

A sensitive PCR assay system for the quantitation of viral genome equivalents: human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV)

✍ T. Hämmerle; M. Himmelspach; F. Dorner; F. G. Falkner 📂 Article 📅 1997 🏛 Springer Vienna 🌐 English ⚖ 279 KB

A new strategy based on recombinant viru

A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1

✍ J. Garcia-Perez; S. Sanchez-Palomino; M. Perez-Olmeda; B. Fernandez; J. Alcami 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

## Abstract The emergence of drug‐resistant variants during antiretroviral therapy is a serious obstacle to sustained suppression of the human immunodeficiency virus type 1 (HIV‐1). For that reason, resistance assays are essential to guide clinicians in the selection of optimal treatment regimens.